NBGAX | VEXPX | NBGAX / VEXPX | |
Total Expense Ratio | 1.34 | 0.44 | 305% |
Annual Report Gross Expense Ratio | 1.34 | 0.44 | 305% |
Fund Existence | 28 years | 58 years | - |
Gain YTD | -2.883 | 1.235 | -233% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.11B | 19.9B | 46% |
Annual Yield % from dividends | 0.00 | 0.40 | - |
Returns for 1 year | -4.00 | -1.90 | 211% |
Returns for 3 years | -6.80 | 5.40 | -126% |
Returns for 5 years | -2.21 | 5.07 | -43% |
Returns for 10 years | -16.70 | 19.92 | -84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQL | 13.86 | 0.21 | +1.54% |
abrdn Life Sciences Investors | |||
ZTWO | 50.78 | -0.01 | -0.02% |
F/M 2-Yr Invmt Grd Corp Bd ETF | |||
SEPP | 29.14 | -0.02 | -0.07% |
PGIM S&P 500 Buffer 12 ETF - Sep | |||
DEM | 46.16 | -0.10 | -0.22% |
WisdomTree Emerging Markets High Div ETF | |||
STXT | 20.16 | -0.09 | -0.44% |
Strive Total Return Bond ETF |